Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Stem Cells. 2015 Apr;33(4):1213–1229. doi: 10.1002/stem.1937

Table. 1.

Age and diagnosis of the patients used in this study

Patients Age ESHF Diagnosis CHD Diagnosis
1 3 mo Congenital Cardiomyopathy (HLHS) VSD
2 5 mo Congenital Cardiomyopathy (DORV, UAVC) VSD
3 8 mo Congenital Cardiomyopathy (HLHS) VSD
4 12.5mo Dilated Cardiomyopathy (DCM) VSD
5 1 year Congenital Cardiomyopathy (HLHS) VSD
6 13 mo Dilated Cardiomyopathy VSD
7 2 years Dilated Cardiomyopathy VSD
8 9 years Dilated Cardiomyopathy DNR
9 10 years Dilated Cardiomyopathy DNR
10 11years Dilated Cardiomyopathy DNR
11 12 years Idiopathic Cardiomyopathy DNR
12 12 years Dilated Cardiomyopathy DNR
13 13 years Dilated Cardiomyopathy DNR
14 14 years Dilated Cardiomyopathy DNR

ESHF = end-stage heart failure; CHD = control heart disease, CCM = congenital Burnt out cardiomyopathy; DCM=dilated cardiomyopathy; ICM = ischemic cardiomyopathy; DNR = Donor heart; HLHS = hypoplastic left heart syndrome; DORV = double outlet right ventricle; UAVC = unbalanced atrioventricular canal, VSD = ventricular septal defect